Financial statements Future Bio 8
Balance sheet data of FUTURE BIO 8
|
Year
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|---|---|
| Total assets | 392 122,32 | 435 480,82 | 426 925,13 | 429 443,84 | 437 643,17 | 592 025,63 | 501 718,78 | 563 726,65 |
| A. Fixed assets | 309 334,20 | 309 334,20 | 309 304,20 | 309 674,20 | 309 674,20 | 370 704,20 | 370 704,20 | 419 484,69 |
| B. Current assets | 82 788,12 | 126 146,62 | 117 620,93 | 119 769,64 | 127 968,97 | 221 321,43 | 131 014,58 | 144 241,96 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 392 122,32 | 435 480,82 | 426 925,13 | 429 443,84 | 437 643,17 | 592 025,63 | 501 718,78 | 563 726,65 |
| A. Equity | -248 932,40 | -212 927,87 | -238 972,01 | -262 023,20 | -279 106,13 | -70 472,84 | -96 878,68 | -148 026,51 |
| B. Liabilities and provisions for liabilities | 641 054,72 | 648 408,69 | 665 897,14 | 691 467,04 | 716 749,30 | 662 498,47 | 598 597,46 | 711 753,16 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 641 054,72 | 648 408,69 | 665 897,14 | 691 467,04 | 716 749,30 | 662 498,47 | 598 597,46 | 711 753,16 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.